Immunotherapy in Resistant Cancer: From the Lab Bench Work to Its Clinical Perspectives

Immunotherapy in Resistant Cancer: From the Lab Bench Work to Its Clinical Perspectives  provides high level knowledge on detailed mechanisms of actions and biological interactions of different immune drugs, with an aim of offering researchers and clinicians cutting-edge therapies to overcome drug resistance. The book explains the latest immunotherapies for different types of cancer, helping users carry out research projects or create alternatives for drug development in the pharmaceutical industry.  Topics discussed include the relationship between immunotherapy and macrophages, immune checkpoints in different types of cancer, immune cocktails in solid tumors, and immune-phenotyping.

Additionally, the book presents basic and clinical data on immunoresistance and glycosylation. This book is a valuable source for cancer researchers, medical doctors, clinicians and members of the biomedical field who must understand certain mechanisms to fight cancer that is resistant to immunotherapy.

Provides basic and clinical evidence based on molecular interactions and clinical studies to address the risks and benefits of cancer immunotherapyPresents the results of new immunotherapy trials, discussing the state-of-the-art in different types of cancerDiscusses targeted therapies approved by the FDA, along with therapies with clinical potential used in basic studies

1. Introduction to immunotherapy: History of immune therapy in cancer
2. Infiltrating immune mass in cancer: what is beyond T lymphocytes
3. Immunotherapy and macrophages
4. Immune checkpoints in different types of cancer: Where and when
5. Immune cocktails in solid tumors
6. Immunotherapy as adjuvant modality
7. Immuno-phenotyping as a diagnosis in cancer: Is it useful in pathology?
8. Immunoresistance: Basic and clinical data
9. Glycosylation: Implications for resistance to immune therapy